Researchers from The James Cook University Hospital in Middlesbrough are appealing for families of children born prematurely, or with conditions such as asthma, diabetes, Down’s syndrome and cerebral palsy, to take part in a national study. James Cook is participating in the University of Oxford’s ARCHIE study, which is looking at whether early antibiotic treatment may prevent these ‘at risk’ children from becoming more unwell when they get flu. The research is funded by the National Institute of Health Research.
South Tees Hospitals NHS Foundation Trust continue to build on their successful record for patient-centred research, development and innovation by leading a pioneering trial which could, ultimately, be used as a first line to detect osteoporosis. In their latest partnership with IBEX Innovations Limited (IBEX), €1.6million has been secured from the European Union’s Horizon 2020 research and innovation programme to investigate the effectiveness of their equipment, which can pick up bone density information alongside conventional X-ray images.
A surgeon-led clinic for people with a neck lump and immediate access to CT scans are amongst the new developments at Teesside’s biggest hospital, which could help speed up the diagnosis of head and neck cancers. A wide variety of specialists including radiologists, pathologists, ear nose and throat specialists and the Oral MaxilloFacial specialists worked together on the potential solutions to provide access to quicker diagnosis and treatment during an innovative workshop at South Tees Institute of Learning, Research and Innovation (LRI), on The James Cook University Hospital site.
A massive “thank you” is being issued to 3,457 patients and more than 200 staff, after South Tees Hospitals NHS Foundation Trust enjoyed a record year in Research & Development. The year 2016 to 2017 became South Tees Hospitals NHS Foundation Trust’s most successful in R&D to date, as the Trust boasted a 17% increase in the number of patients taking part in clinical trials compared with the previous year.
A County Durham woman who has been battling ovarian cancer for more than five years has become the first in the UK to benefit from a new drug to prevent a recurrence of the disease. The 46-year-old, who does not want to be named, is a patient of Dr Talal Mansy, a consultant medical oncologist at The James Cook University Hospital in Middlesbrough.
A determined grandad who is battling prostate cancer has spoken of his joy at joining Jeff Stelling on his March for Men walk – and vowed to get involved with the event again next year. Roofer Ken Bashford, 60, of New Marske, walked with Jeff Stelling and other Prostate Cancer UK fundraisers from Middlesbrough FC’s Riverside Stadium to the Transporter Bridge, as part of Sky Soccer Saturday anchor’s effort to complete 15 marathons in 15 days, taking in 40 football stadiums across the country, from Exeter City FC to Newcastle United.
When self-employed roofer and proud grandad Ken Bashford received an email from Prostate Cancer UK inviting him to take part in local celebrity Jeff Stelling’s latest marathon effort to fight the disease, he was “over the moon”. It was a much-welcomed high point in what has been a rollercoaster ride for the 60-year-old, from Marske, since being diagnosed with prostate cancer himself following a simple blood test in May 2015.